Cargos activos de Erlich Yaniv
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Eleven Therapeutics Ltd.
 Eleven Therapeutics Ltd. Medical/Nursing ServicesHealth Services Eleven Therapeutics Ltd. is an Israeli biotech company that combines artificial intelligence, functional assays, and combinatorial chemistry to develop RNAi therapeutics. The company was founded in 2020 by a group of interdisciplinary scientists and has three collaborative hubs located in undisclosed locations. The company is based in an undisclosed location. Eleven Therapeutics is currently focused on developing siRNA treatments for respiratory diseases using its flagship invention, SCSI-RNA™. This fully programmable molecule is designed to address the delivery, durability, and efficacy challenges of any disease and biological target of interest. The company was founded by Erlich Yaniv, Shaun Ilan, Greg Hannon, and Erlich Yaniv has been the CEO since incorporation. | Director Ejecutivo | 01/01/2017 | - |
| Director Técnico/Científico/I+D | - | - | |
| Fundador | - | - |
Historial de carrera de Erlich Yaniv
Estadísticas
Internacional
| Israel | 2 |
Operativa
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectorial
| Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Eleven Therapeutics Ltd.
Eleven Therapeutics Ltd. Medical/Nursing ServicesHealth Services Eleven Therapeutics Ltd. is an Israeli biotech company that combines artificial intelligence, functional assays, and combinatorial chemistry to develop RNAi therapeutics. The company was founded in 2020 by a group of interdisciplinary scientists and has three collaborative hubs located in undisclosed locations. The company is based in an undisclosed location. Eleven Therapeutics is currently focused on developing siRNA treatments for respiratory diseases using its flagship invention, SCSI-RNA™. This fully programmable molecule is designed to address the delivery, durability, and efficacy challenges of any disease and biological target of interest. The company was founded by Erlich Yaniv, Shaun Ilan, Greg Hannon, and Erlich Yaniv has been the CEO since incorporation. | Health Services |
- Bolsa de valores
- Insiders
- Erlich Yaniv
- Experiencia
